EP2694043
Samsetningar sem innihalda brexpíprasól eða salt þar af og annað lyf til að nota við að meðhöndla miðtaugakerfistruflun
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
4.4.2012EP published:
1.11.2017EP application number:
12719460.3
EP translation filed:
10.1.2018Grant published:
15.2.2018EPO information:
European Patent Register
Max expiry date:
3.4.2032Expiry date:
3.4.2020
Title:
COMBINATIONS COMPRISING BREXPIPRAZOLE OR A SALT THEREOF AND A SECOND DRUG FOR USE IN THE TREATMENT OF A CNS DISORDER
Timeline
Today
4.4.2012EP application
1.11.2017EP Publication
10.1.2018Translation submitted
15.2.2018Registration published
3.4.2020Expires
Owner
Name:
Otsuka Pharmaceutical Co., Ltd.Address:
2-9, Kanda-Tsukasamachi Chiyoda-ku, 101-8535, Tokyo, JP
Inventor
Name:
HIROSE, TsuyoshiAddress:
Osaka-shi, Osaka, JP
Name:
MAEDA, KenjiAddress:
Osaka-shi, Osaka, JP
Name:
KIKUCHI, TetsuroAddress:
Osaka-shi, Osaka, JP
Name:
TODA, MasafumiAddress:
Osaka-shi, Osaka, JP
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201161471911 PDate:
5.4.2011Country:
US
Number:
201161580540 PDate:
27.12.2011Country:
US
Classification
Categories:
A61K 31/00, A61K 31/496, A61P 25/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 27.3.2018
Expires: 3.4.2019
Payer: Árnason Faktor
Number: 8
Paid: 8.3.2019
Expires: 3.4.2020
Payer: Árnason Faktor